Panacea Life Sciences Holdings, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
Panacea Life Sciences Holdings, Inc. (PLSH) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $313.26 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2021-11-22
- Panacea Life Sciences Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2021-09-30 was $110.42K, a 90.06% increase year-over-year.
- Panacea Life Sciences Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2020-12-31 was -$127.34K.
- Panacea Life Sciences Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2020-09-30 was $58.10K.
- Panacea Life Sciences Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2019-12-31 was $0.00.
- Panacea Life Sciences Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2020 was $121.69K.
- Panacea Life Sciences Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2019 was $0.00.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month as first filed | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month as first filed | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|---|---|
| 2021-09-30 | $110.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-22 | $313.26K 10-Q · filed 2021-11-22 | ||||
| 2021-06-30 | $202.84K 10-Q · filed 2021-08-23 | |||||
| 2020-12-31 | -$127.34K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23 | -$69.25K derived: sum of 2 quarters · filed 2021-11-22 | $121.69K 10-K/A · filed 2021-04-23 | |||
| 2020-09-30 | $58.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-22 | $249.04K 10-Q · filed 2021-11-22 | $121.69K 10-Q · filed 2020-11-18 | |||
| 2020-06-30 | $190.94K 10-Q · filed 2021-08-23 | $80.12K 10-Q · filed 2020-08-19 | ||||
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23 | $0.00 derived: sum of 2 quarters · filed 2021-04-23 | $0.00 10-K/A · filed 2021-04-23 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-18 | $0.00 10-Q · filed 2020-11-18 | ||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-19 |